{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:04:55Z","timestamp":1790643895705,"version":"4.1.0"},"reference-count":195,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2019.02301","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T14:28:37Z","timestamp":1570199317000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic Targets"],"prefix":"10.3389","volume":"10","author":[{"given":"Tiziana","family":"Vaisitti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Arruga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Deaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/imr.12571","article-title":"Extracellular nucleosides and nucleotides as immunomodulators","volume":"280","author":"Kepp","year":"2017","journal-title":"Immunol Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"E1222","DOI":"10.3390\/ijms19041222","article-title":"Mechanisms of ATP release by inflammatory cells","volume":"19","author":"Dosch","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.coph.2019.02.010","article-title":"The role of the P2X7 receptor in myeloid-derived suppressor cells and immunosuppression","volume":"47","author":"Principi","year":"2019","journal-title":"Curr Opin Pharmacol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/nrc3613","article-title":"Immunity, inflammation and cancer: a leading role for adenosine","volume":"13","author":"Antonioli","year":"2013","journal-title":"Nat Rev Cancer."},{"key":"B5","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/nature13085","article-title":"Nucleotide signalling during inflammation","volume":"509","author":"Idzko","year":"2014","journal-title":"Nature."},{"key":"B6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00281-014-0417-9","article-title":"Ectoenzymes in leukocyte migration and their therapeutic potential","volume":"36","author":"Salmi","year":"2014","journal-title":"Semin Immunopathol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3389\/fphar.2017.00661","article-title":"Purinergic signalling: therapeutic developments","volume":"8","author":"Burnstock","year":"2017","journal-title":"Front Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41568-018-0037-0","article-title":"Extracellular ATP and P2 purinergic signalling in the tumour microenvironment","volume":"18","author":"Di Virgilio","year":"2018","journal-title":"Nat Rev Cancer."},{"key":"B9","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","article-title":"Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade","volume":"1783","author":"Yegutkin","year":"2008","journal-title":"Biochim Biophys Acta."},{"key":"B10","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular function and molecular structure of ecto-nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic Signal."},{"key":"B11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s00109-012-0991-z","article-title":"Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states","volume":"91","author":"Longhi","year":"2013","journal-title":"J Mol Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s11302-012-9349-9","article-title":"Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go?","volume":"9","author":"Kumar","year":"2013","journal-title":"Purinergic Signal."},{"key":"B13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41389-017-0011-9","article-title":"The hypoxic tumour microenvironment","volume":"7","author":"Petrova","year":"2018","journal-title":"Oncogenesis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"E1167","DOI":"10.3390\/ijms19041167","article-title":"Targeting the adenosinergic axis in chronic lymphocytic leukemia: a way to disrupt the tumor niche?","volume":"19","author":"Vaisitti","year":"2018","journal-title":"Int J Mol Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/0968-0004(92)90337-9","article-title":"Similarities in amino acid sequences of Aplysia ADP-ribosyl cyclase and human lymphocyte antigen CD38","volume":"17","author":"States","year":"1992","journal-title":"Trends Biochem Sci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1006\/bbrc.1994.2325","article-title":"Molecular cloning of murine BST-1 having homology with CD38 and Aplysia ADP-ribosyl cyclase","volume":"203","author":"Itoh","year":"1994","journal-title":"Biochem Biophys Res Commun."},{"key":"B17","doi-asserted-by":"publisher","first-page":"986","DOI":"10.2741\/4262","article-title":"The ADP-ribosyl cyclases\u2013the current evolutionary state of the ARCs","volume":"19","author":"Ferrero","year":"2014","journal-title":"Front Biosci."},{"key":"B18","doi-asserted-by":"publisher","first-page":"334","DOI":"10.2119\/2006-00094.Malavasi","article-title":"CD38 and CD157 as receptors of the immune system: a bridge between innate and adaptive immunity","volume":"12","author":"Malavasi","year":"2006","journal-title":"Mol Med."},{"key":"B19","doi-asserted-by":"crossref","first-page":"878","DOI":"10.4049\/jimmunol.145.3.878","article-title":"CD38 molecule: structural and biochemical analysis on human T lymphocytes, thymocytes, and plasma cells","volume":"145","author":"Alessio","year":"1990","journal-title":"J Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1152\/physrev.00035.2007","article-title":"Evolution and function of the ADP ribosyl cyclase\/CD38 gene family in physiology and pathology","volume":"88","author":"Malavasi","year":"2008","journal-title":"Physiol Rev."},{"key":"B21","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1038\/nsb1196-957","article-title":"Crystal structure of Aplysia ADP ribosyl cyclase, a homologue of the bifunctional ectozyme CD38","volume":"3","author":"Prasad","year":"1996","journal-title":"Nat Struct Biol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.str.2005.05.012","article-title":"Crystal structure of human CD38 extracellular domain","volume":"13","author":"Liu","year":"2005","journal-title":"Structure."},{"key":"B23","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.1074\/jbc.M609093200","article-title":"Structural basis for formation and hydrolysis of the calcium messenger cyclic ADP-ribose by human CD38","volume":"282","author":"Liu","year":"2007","journal-title":"J Biol Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"24825","DOI":"10.1074\/jbc.M701653200","article-title":"Catalysis-associated conformational changes revealed by human CD38 complexed with a non-hydrolyzable substrate analog","volume":"282","author":"Liu","year":"2007","journal-title":"J Biol Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.imlet.2018.06.007","article-title":"CD157: from immunoregulatory protein to potential therapeutic target","volume":"205","author":"Ortolan","year":"2019","journal-title":"Immunol Lett."},{"key":"B26","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3389\/fimmu.2019.00760","article-title":"CD38 in adenosinergic pathways and metabolic re-programming in human multiple myeloma cells: in-tandem insights from basic science to therapy","volume":"10","author":"Horenstein","year":"2019","journal-title":"Front Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/imr.12528","article-title":"The ectonucleotidases CD39 and CD73: novel checkpoint inhibitor targets","volume":"276","author":"Allard","year":"2017","journal-title":"Immunol Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"31633","DOI":"10.1074\/jbc.R112.349464","article-title":"Cyclic ADP-ribose and nicotinic acid adenine dinucleotide phosphate (NAADP) as messengers for calcium mobilization","volume":"287","author":"Lee","year":"2012","journal-title":"J Biol Chem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"31419","DOI":"10.1074\/jbc.M606625200","article-title":"Extracellular NAD+ is an agonist of the human P2Y11 purinergic receptor in human granulocytes","volume":"281","author":"Moreschi","year":"2006","journal-title":"J Biol Chem."},{"key":"B30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ceca.2009.08.004","article-title":"Extracellular NAD(+) induces a rise in [Ca(2+)](i) in activated human monocytes via engagement of P2Y(1) and P2Y(11) receptors","volume":"46","author":"Klein","year":"2009","journal-title":"Cell Calcium."},{"key":"B31","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/15640","article-title":"A new function for CD38\/ADP-ribosyl cyclase in nuclear Ca2+ homeostasis","volume":"1","author":"Adebanjo","year":"1999","journal-title":"Nat Cell Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2119\/2006-00086.Lee","article-title":"Structure and enzymatic functions of human CD38","volume":"12","author":"Lee","year":"2006","journal-title":"Mol Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/35079092","article-title":"LTRPC7 is a Mg","volume":"411","author":"Nadler","year":"2001","journal-title":"Nature."},{"key":"B34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0898-6568(99)00004-2","article-title":"Cyclic ADP-ribose: a novel Ca2+-mobilising second messenger","volume":"11","author":"Guse","year":"1999","journal-title":"Cell Signal."},{"key":"B35","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/0014-5793(94)01279-2","article-title":"ADP ribosyl cyclase activity of a novel bone marrow stromal cell surface molecule, BST-1","volume":"356","author":"Hirata","year":"1994","journal-title":"FEBS Lett."},{"key":"B36","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1006\/bbrc.1996.0327","article-title":"Pancreatic islet cells express BST-1, a CD38-like surface molecule having ADP-ribosyl cyclase activity","volume":"219","author":"Kajimoto","year":"1996","journal-title":"Biochem Biophys Res Commun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1006\/prep.1997.0811","article-title":"Functional expression of secreted mouse BST-1 in yeast","volume":"12","author":"Hussain","year":"1998","journal-title":"Protein Expr Purif."},{"key":"B38","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4049\/jimmunol.160.1.395","article-title":"Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member","volume":"160","author":"Deaglio","year":"1998","journal-title":"J Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1074\/jbc.M107474200","article-title":"CD38 is associated with lipid rafts and upon receptor stimulation leads to Akt\/protein kinase B and Erk activation in the absence of the CD3-zeta immune receptor tyrosine-based activation motifs","volume":"277","author":"Zubiaur","year":"2002","journal-title":"J Biol Chem."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1182\/blood.V99.7.2490","article-title":"Human CD38 and CD16 are functionally dependent and physically associated in natural killer cells","volume":"99","author":"Deaglio","year":"2002","journal-title":"Blood."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1182\/blood-2005-07-2913","article-title":"CD38 orchestrates migration, survival, and Th1 immune response of human mature dendritic cells","volume":"107","author":"Frasca","year":"2006","journal-title":"Blood."},{"key":"B42","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.1182\/blood-2006-12-061812","article-title":"CD38\/CD19: a lipid raft-dependent signaling complex in human B cells","volume":"109","author":"Deaglio","year":"2007","journal-title":"Blood."},{"key":"B43","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/imm.12370","article-title":"CD38 expression in early B-cell precursors contributes to extracellular signal-regulated kinase-mediated apoptosis","volume":"144","author":"Romero-Ramirez","year":"2015","journal-title":"Immunology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1038\/nm1101-1209","article-title":"Cyclic ADP-ribose production by CD38 regulates intracellular calcium release, extracellular calcium influx and chemotaxis in neutrophils and is required for bacterial clearance in vivo","volume":"7","author":"Partida-Sanchez","year":"2001","journal-title":"Nat Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S1074-7613(04)00048-2","article-title":"Regulation of dendritic cell trafficking by the ADP-ribosyl cyclase CD38: impact on the development of humoral immunity","volume":"20","author":"Partida-Sanchez","year":"2004","journal-title":"Immunity."},{"key":"B46","doi-asserted-by":"publisher","first-page":"18681","DOI":"10.1074\/jbc.M111.227876","article-title":"The CD157-integrin partnership controls transendothelial migration and adhesion of human monocytes","volume":"286","author":"Lo Buono","year":"2011","journal-title":"J Biol Chem."},{"key":"B47","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.imlet.2018.06.008","article-title":"A phylogenetic view of the leukocyte ectonucleotidases","volume":"205","author":"Ferrero","year":"2019","journal-title":"Immunol Lett."},{"key":"B48","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.tibs.2005.08.005","article-title":"NPP-type ectophosphodiesterases: unity in diversity","volume":"30","author":"Stefan","year":"2005","journal-title":"Trends Biochem Sci."},{"key":"B49","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1046\/j.1432-1033.2001.01896.x","article-title":"The C-terminal cysteine-rich region dictates specific catalytic properties in chimeras of the ectonucleotidases NTPDase1 and NTPDase2","volume":"268","author":"Heine","year":"2001","journal-title":"Eur J Biochem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1021\/bi015563h","article-title":"Transmembrane domains confer different substrate specificities and adenosine diphosphate hydrolysis mechanisms on CD39, CD39L1, and chimeras","volume":"41","author":"Grinthal","year":"2002","journal-title":"Biochemistry."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1074\/jbc.275.3.2057","article-title":"Palmitoylation targets CD39\/endothelial ATP diphosphohydrolase to caveolae","volume":"275","author":"Koziak","year":"2000","journal-title":"J Biol Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"41518","DOI":"10.1074\/jbc.M104415200","article-title":"Mammalian plasma membrane ecto-nucleoside triphosphate diphosphohydrolase 1, CD39, is not active intracellularly. The N-glycosylation state of CD39 correlates with surface activity and localization","volume":"276","author":"Zhong","year":"2001","journal-title":"J Biol Chem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s11302-005-5302-5","article-title":"Physiological roles for ecto-5'-nucleotidase (CD73)","volume":"2","author":"Colgan","year":"2006","journal-title":"Purinergic Signal."},{"key":"B54","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11302-006-9003-5","article-title":"The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance","volume":"2","author":"Robson","year":"2006","journal-title":"Purinergic Signal."},{"key":"B55","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/sj.bjp.0703136","article-title":"Effect of shear stress on the release of soluble ecto-enzymes ATPase and 5\u2032-nucleotidase along with endogenous ATP from vascular endothelial cells","volume":"129","author":"Yegutkin","year":"2000","journal-title":"Br J Pharmacol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/bj20021687","article-title":"Biochemical and mass spectrometric characterization of soluble ecto-5'-nucleotidase from bull seminal plasma","volume":"372","author":"Fini","year":"2003","journal-title":"Biochem J."},{"key":"B57","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.str.2012.10.001","article-title":"Crystal structure of the human ecto-5\u2032-nucleotidase (CD73): insights into the regulation of purinergic signaling","volume":"20","author":"Knapp","year":"2012","journal-title":"Structure."},{"key":"B58","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11302-005-5301-6","article-title":"The structure of the nucleoside triphosphate diphosphohydrolases (NTPDases) as revealed by mutagenic and computational modeling analyses","volume":"2","author":"Kirley","year":"2006","journal-title":"Purinergic Signal."},{"key":"B59","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1042\/BJ20051568","article-title":"RanBPM associates with CD39 and modulates ecto-nucleotidase activity","volume":"396","author":"Wu","year":"2006","journal-title":"Biochem J."},{"key":"B60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1600-065X.1998.tb01574.x","article-title":"Ecto-enzyme and signaling functions of lymphocyte CD73","volume":"161","author":"Resta","year":"1998","journal-title":"Immunol Rev."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/ijc.28456","article-title":"Anti-CD73 therapy impairs tumor angiogenesis","volume":"134","author":"Allard","year":"2014","journal-title":"Int J Cancer."},{"key":"B62","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2217\/imt.15.106","article-title":"CD73-adenosine: a next-generation target in immuno-oncology","volume":"8","author":"Allard","year":"2016","journal-title":"Immunotherapy."},{"key":"B63","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1182\/blood-2013-09-524827","article-title":"Natural killer cells acquire CD73 expression upon exposure to mesenchymal stem cells","volume":"123","author":"Chatterjee","year":"2014","journal-title":"Blood."},{"key":"B64","doi-asserted-by":"crossref","first-page":"3574","DOI":"10.4049\/jimmunol.153.8.3574","article-title":"The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization","volume":"153","author":"Maliszewski","year":"1994","journal-title":"J Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s11302-006-9050-y","article-title":"CD39 and control of cellular immune responses","volume":"3","author":"Dwyer","year":"2007","journal-title":"Purinergic Signal."},{"key":"B66","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1182\/blood-2013-02-482406","article-title":"Adenosine production by human B cells and B cell-mediated suppression of activated T cells","volume":"122","author":"Saze","year":"2013","journal-title":"Blood."},{"key":"B67","doi-asserted-by":"publisher","first-page":"e1082703","DOI":"10.1080\/2162402X.2015.1082703","article-title":"Phenotypic and functional characteristics of CD39(high) human regulatory B cells (Breg)","volume":"5","author":"Figueiro","year":"2016","journal-title":"Oncoimmunology."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.celrep.2013.05.022","article-title":"Dependence of immunoglobulin class switch recombination in B cells on vesicular release of ATP and CD73 ectonucleotidase activity","volume":"3","author":"Schena","year":"2013","journal-title":"Cell Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"8819","DOI":"10.1038\/ncomms9819","article-title":"NADH oxidase-dependent CD39 expression by CD8(+) T cells modulates interferon gamma responses via generation of adenosine","volume":"6","author":"Bai","year":"2015","journal-title":"Nat Commun."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.celrep.2016.01.002","article-title":"Expression of CD39 on activated T cells impairs their survival in older individuals","volume":"14","author":"Fang","year":"2016","journal-title":"Cell Rep."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1002\/eji.201545939","article-title":"IL-12 and IL-4 activate a CD39-dependent intrinsic peripheral tolerance mechanism in CD8(+) T cells","volume":"46","author":"Noble","year":"2016","journal-title":"Eur J Immunol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"3062","DOI":"10.1002\/eji.201242623","article-title":"CD73 is a phenotypic marker of effector memory Th17 cells in inflammatory bowel disease","volume":"42","author":"Doherty","year":"2012","journal-title":"Eur J Immunol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1084\/jem.20062512","article-title":"Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression","volume":"204","author":"Deaglio","year":"2007","journal-title":"J Exp Med."},{"key":"B74","doi-asserted-by":"publisher","first-page":"7602","DOI":"10.4049\/jimmunol.0901881","article-title":"CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis","volume":"183","author":"Fletcher","year":"2009","journal-title":"J Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"e87956","DOI":"10.1371\/journal.pone.0087956","article-title":"Characterization of human CD39+ Th17 cells with suppressor activity and modulation in inflammatory bowel disease","volume":"9","author":"Longhi","year":"2014","journal-title":"PLoS ONE."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1158\/0008-5472.CAN-10-4246","article-title":"CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis","volume":"71","author":"Stagg","year":"2011","journal-title":"Cancer Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/cei.12354","article-title":"Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells","volume":"177","author":"Schuler","year":"2014","journal-title":"Clin Exp Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fimmu.2012.00190","article-title":"The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway","volume":"3","author":"Ohta","year":"2012","journal-title":"Front Immunol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1038\/leu.2017.91","article-title":"The emerging roles of tumor-derived exosomes in hematological malignancies","volume":"31","author":"Boyiadzis","year":"2017","journal-title":"Leukemia."},{"key":"B80","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/cei.12974","article-title":"Exosomes carrying immunoinhibitory proteins and their role in cancer","volume":"189","author":"Whiteside","year":"2017","journal-title":"Clin Exp Immunol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"7172","DOI":"10.4049\/jimmunol.166.12.7172","article-title":"The P2Y11 receptor mediates the ATP-induced maturation of human monocyte-derived dendritic cells","volume":"166","author":"Wilkin","year":"2001","journal-title":"J Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1182\/blood-2008-02-136325","article-title":"Adenosine receptors in regulation of dendritic cell differentiation and function","volume":"112","author":"Novitskiy","year":"2008","journal-title":"Blood."},{"key":"B83","doi-asserted-by":"publisher","first-page":"e31205","DOI":"10.1371\/journal.pone.0031205","article-title":"Differential macrophage activation alters the expression profile of NTPDase and ecto-5\u2032-nucleotidase","volume":"7","author":"Zanin","year":"2012","journal-title":"PLoS ONE."},{"key":"B84","doi-asserted-by":"publisher","first-page":"584","DOI":"10.4049\/jimmunol.1401024","article-title":"Adenosine 5\u2032-monophosphate-activated protein kinase regulates IL-10-mediated anti-inflammatory signaling pathways in macrophages","volume":"194","author":"Zhu","year":"2015","journal-title":"J Immunol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0145-2126(99)00147-2","article-title":"Increased CD38 expression is associated with favorable prognosis in adult acute leukemia","volume":"24","author":"Keyhani","year":"2000","journal-title":"Leuk Res."},{"key":"B86","first-page":"355","article-title":"Immunophenotypic significance of the \u201clymphoid\u201d CD38 antigen in myeloid blood malignancies","volume":"40","author":"Marinov","year":"1993","journal-title":"Neoplasma."},{"key":"B87","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.3324\/haematol.2018.192757","article-title":"CD38 as a therapeutic target for adult acute myeloid leukemia and T-cell acute lymphoblastic leukemia","volume":"104","author":"Naik","year":"2018","journal-title":"Haematologica."},{"key":"B88","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1365-2141.2007.06526.x","article-title":"Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH","volume":"137","author":"Parry-Jones","year":"2007","journal-title":"Br J Haematol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"3352","DOI":"10.1182\/blood-2007-04-083832","article-title":"CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells","volume":"110","author":"Damle","year":"2007","journal-title":"Blood."},{"key":"B90","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1182\/blood-2011-06-275610","article-title":"CD38 and chronic lymphocytic leukemia: a decade later","volume":"118","author":"Malavasi","year":"2011","journal-title":"Blood."},{"key":"B91","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/leu.2013.350","article-title":"New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)","volume":"28","author":"Ocio","year":"2014","journal-title":"Leukemia."},{"key":"B92","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/sj.leu.2403262","article-title":"Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells","volume":"18","author":"Suzuki","year":"2004","journal-title":"Leukemia."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00277-015-2359-2","article-title":"CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK\/T cell lymphoma, nasal type","volume":"94","author":"Wang","year":"2015","journal-title":"Ann Hematol."},{"key":"B94","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/367645a0","article-title":"A cell initiating human acute myeloid leukaemia after transplantation into SCID mice","volume":"367","author":"Lapidot","year":"1994","journal-title":"Nature."},{"key":"B95","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/leu.2008.83","article-title":"CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL","volume":"22","author":"Kong","year":"2008","journal-title":"Leukemia."},{"key":"B96","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/nrc3368","article-title":"Cancer stem cell definitions and terminology: the devil is in the details","volume":"12","author":"Valent","year":"2012","journal-title":"Nat Rev Cancer."},{"key":"B97","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1038\/leu.2014.228","article-title":"CD34(+)CD38(-)CD58(-) cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"28","author":"Kong","year":"2014","journal-title":"Leukemia."},{"key":"B98","doi-asserted-by":"publisher","first-page":"6520","DOI":"10.1158\/1078-0432.CCR-05-0468","article-title":"High stem cell frequency in acute myeloid leukemia at diagnosis predicts high minimal residual disease and poor survival","volume":"11","author":"van Rhenen","year":"2005","journal-title":"Clin Cancer Res."},{"key":"B99","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1182\/blood-2011-06-364182","article-title":"A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia","volume":"119","author":"Gerber","year":"2012","journal-title":"Blood."},{"key":"B100","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1038\/s41375-018-0326-3","article-title":"CD34(+)CD38(-) leukemic stem cell frequency to predict outcome in acute myeloid leukemia","volume":"33","author":"Zeijlemaker","year":"2018","journal-title":"Leukemia."},{"key":"B101","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1038\/bmt.2014.274","article-title":"Presence of CD34(+)CD38(-)CD58(-) leukemia-propagating cells at diagnosis identifies patients at high risk of relapse with Ph chromosome-positive ALL after allo-hematopoietic SCT","volume":"50","author":"Kong","year":"2015","journal-title":"Bone Marrow Transplant."},{"key":"B102","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3109\/10428194.2013.807924","article-title":"High proportion of CD34+\/CD38-cells is positively correlated with poor prognosis in newly diagnosed childhood acute lymphoblastic leukemia","volume":"55","author":"Long","year":"2014","journal-title":"Leuk Lymphoma."},{"key":"B103","doi-asserted-by":"publisher","first-page":"35707","DOI":"10.18632\/oncotarget.16060","article-title":"Targeting CD157 in AML using a novel, Fc-engineered antibody construct","volume":"8","author":"Krupka","year":"2017","journal-title":"Oncotarget."},{"key":"B104","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.1182\/blood-2012-11-468702","article-title":"Leukemia surfaceome analysis reveals new disease-associated features","volume":"121","author":"Mirkowska","year":"2013","journal-title":"Blood."},{"key":"B105","doi-asserted-by":"publisher","first-page":"25602","DOI":"10.18632\/oncotarget.4693","article-title":"A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation","volume":"6","author":"Morandi","year":"2015","journal-title":"Oncotarget."},{"key":"B106","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1182\/blood.V98.9.2633","article-title":"Clinical significance of CD38 expression in chronic lymphocytic leukemia","volume":"98","author":"Del Poeta","year":"2001","journal-title":"Blood."},{"key":"B108","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1182\/blood.V98.1.181","article-title":"CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia","volume":"98","author":"Ibrahim","year":"2001","journal-title":"Blood."},{"key":"B109","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1046\/j.1365-2141.2001.03149.x","article-title":"Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia","volume":"115","author":"Jelinek","year":"2001","journal-title":"Br J Haematol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0145-2126(01)00049-2","article-title":"Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia","volume":"25","author":"Morabito","year":"2001","journal-title":"Leuk Res."},{"key":"B111","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/sj.leu.2402339","article-title":"CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia","volume":"16","author":"Durig","year":"2002","journal-title":"Leukemia."},{"key":"B112","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/sj.leu.2403707","article-title":"Combined analysis of ZAP-70 and CD38 expression as a predictor of disease progression in B-cell chronic lymphocytic leukemia","volume":"19","author":"Schroers","year":"2005","journal-title":"Leukemia."},{"key":"B113","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/sj.leu.2404087","article-title":"CD49d in B-cell chronic lymphocytic leukemia: correlated expression with CD38 and prognostic relevance","volume":"20","author":"Zucchetto","year":"2006","journal-title":"Leukemia."},{"key":"B114","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416","article-title":"V(H) mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia","volume":"100","author":"Krober","year":"2002","journal-title":"Blood."},{"key":"B115","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrclinonc.2010.167","article-title":"Prognostic factors in chronic lymphocytic leukemia-what do we need to know?","volume":"8","author":"Cramer","year":"2011","journal-title":"Nat Rev Clin Oncol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1080\/10428194.2017.1397660","article-title":"The mutational landscape of small lymphocytic lymphoma compared to non-early stage chronic lymphocytic leukemia","volume":"59","author":"Martinez-Trillos","year":"2018","journal-title":"Leuk Lymphoma."},{"key":"B117","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1182\/blood-2010-12-327858","article-title":"Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia","volume":"118","author":"Ouillette","year":"2011","journal-title":"Blood."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1038\/leu.2012.14","article-title":"Longitudinal genome-wide analysis of patients with chronic lymphocytic leukemia reveals complex evolution of clonal architecture at disease progression and at the time of relapse","volume":"26","author":"Braggio","year":"2012","journal-title":"Leukemia."},{"key":"B119","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1002\/cyto.b.20590","article-title":"A novel scoring system combining expression of CD23, CD20, and CD38 with platelet count predicts for the presence of the t(11;14) translocation of mantle cell lymphoma","volume":"80","author":"Medd","year":"2011","journal-title":"Cytometry B Clin Cytom."},{"key":"B120","doi-asserted-by":"publisher","first-page":"4042","DOI":"10.1182\/blood-2002-11-3456","article-title":"Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations","volume":"101","author":"Camacho","year":"2003","journal-title":"Blood."},{"key":"B121","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","article-title":"A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease","volume":"101","author":"Orchard","year":"2003","journal-title":"Blood."},{"key":"B122","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1056\/NEJMc1605684","article-title":"Targeting CD38 in refractory extranodal natural killer cell-T-cell lymphoma","volume":"375","author":"Hari","year":"2016","journal-title":"N Engl J Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nrc2943","article-title":"Acute promyelocytic leukaemia: novel insights into the mechanisms of cure","volume":"10","author":"de The","year":"2010","journal-title":"Nat Rev Cancer."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1111\/j.1349-7006.2011.02045.x","article-title":"Advances in therapies for acute promyelocytic leukemia","volume":"102","author":"Kamimura","year":"2011","journal-title":"Cancer Sci."},{"key":"B125","first-page":"1746","article-title":"Retinoic acid-induced expression of CD38 antigen in myeloid cells is mediated through retinoic acid receptor-alpha","volume":"54","author":"Drach","year":"1994","journal-title":"Cancer Res."},{"key":"B126","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3109\/10428199909058401","article-title":"Retinoid-mediated signaling pathways in CD38 antigen expression in myeloid leukemia cells","volume":"32","author":"Mehta","year":"1999","journal-title":"Leuk Lymphoma."},{"key":"B127","doi-asserted-by":"publisher","first-page":"17406","DOI":"10.1038\/s41598-017-17720-4","article-title":"Probing the requirement for CD38 in retinoic acid-induced HL-60 cell differentiation with a small molecule dimerizer and genetic knockout","volume":"7","author":"MacDonald","year":"2017","journal-title":"Sci Rep."},{"key":"B128","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.leukres.2006.07.004","article-title":"Retinoic acid-induced CD38 antigen promotes leukemia cells attachment and interferon-gamma\/interleukin-1beta-dependent apoptosis of endothelial cells: implications in the etiology of retinoic acid syndrome","volume":"31","author":"Gao","year":"2007","journal-title":"Leuk Res."},{"key":"B129","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood.V88.4.1365.bloodjournal8841365","article-title":"CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis","volume":"88","author":"Zupo","year":"1996","journal-title":"Blood."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1182\/blood-2002-06-1822","article-title":"Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia","volume":"101","author":"Lanham","year":"2003","journal-title":"Blood."},{"key":"B131","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/j.1365-2141.2009.08032.x","article-title":"Prognostic relevance of in vitro response to cell stimulation via surface IgD in binet stage a CLL","volume":"149","author":"Morabito","year":"2010","journal-title":"Br J Haematol."},{"key":"B132","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1182\/blood-2003-03-0989","article-title":"CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells","volume":"102","author":"Deaglio","year":"2003","journal-title":"Blood."},{"key":"B133","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1182\/blood-2004-10-3873","article-title":"CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival","volume":"105","author":"Deaglio","year":"2005","journal-title":"Blood."},{"key":"B134","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2119\/molmed.2009.00146","article-title":"CD38\/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells","volume":"16","author":"Deaglio","year":"2010","journal-title":"Mol Med."},{"key":"B135","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.V96.8.2655","article-title":"Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1","volume":"96","author":"Burger","year":"2000","journal-title":"Blood."},{"key":"B136","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/leu.2010.36","article-title":"CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells","volume":"24","author":"Vaisitti","year":"2010","journal-title":"Leukemia."},{"key":"B137","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3324\/haematol.2009.014381","article-title":"Genetic modification of primary chronic lymphocytic leukemia cells with a lentivirus expressing CD38","volume":"95","author":"Pearce","year":"2010","journal-title":"Haematologica."},{"key":"B138","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/leu.2011.369","article-title":"The CD49d\/CD29 complex is physically and functionally associated with CD38 in B-cell chronic lymphocytic leukemia cells","volume":"26","author":"Zucchetto","year":"2012","journal-title":"Leukemia."},{"key":"B139","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/leu.2012.260","article-title":"CD38 signals upregulate expression and functions of matrix metalloproteinase-9 in chronic lymphocytic leukemia cells","volume":"27","author":"Vaisitti","year":"2013","journal-title":"Leukemia."},{"key":"B140","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/leu.2014.207","article-title":"The enzymatic activities of CD38 enhance CLL growth and trafficking: implications for therapeutic targeting","volume":"29","author":"Vaisitti","year":"2015","journal-title":"Leukemia"},{"key":"B141","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/imr.12233","article-title":"Targeting the bone marrow microenvironment in multiple myeloma","volume":"263","author":"Kawano","year":"2015","journal-title":"Immunol Rev."},{"key":"B142","doi-asserted-by":"publisher","first-page":"e1458809","DOI":"10.1080\/2162402X.2018.1458809","article-title":"Microvesicles released from multiple myeloma cells are equipped with ectoenzymes belonging to canonical and non-canonical adenosinergic pathways and produce adenosine from ATP and NAD()","volume":"7","author":"Morandi","year":"2018","journal-title":"Oncoimmunology."},{"key":"B143","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1158\/0008-5472.CAN-18-0773","article-title":"CD38-Driven mitochondrial trafficking promotes bioenergetic plasticity in multiple myeloma","volume":"79","author":"Marlein","year":"2019","journal-title":"Cancer Res."},{"key":"B144","doi-asserted-by":"publisher","first-page":"4290","DOI":"10.1158\/1078-0432.CCR-16-3192","article-title":"Targeting CD38 suppresses induction and function of T regulatory cells to mitigate immunosuppression in multiple myeloma","volume":"23","author":"Feng","year":"2017","journal-title":"Clin Cancer Res."},{"key":"B145","doi-asserted-by":"publisher","first-page":"6267","DOI":"10.1182\/blood-2010-12-324004","article-title":"New markers for minimal residual disease detection in acute lymphoblastic leukemia","volume":"117","author":"Coustan-Smith","year":"2011","journal-title":"Blood."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.3109\/10428194.2015.1070153","article-title":"The application of CD73 in minimal residual disease monitoring using flow cytometry in B-cell acute lymphoblastic leukemia","volume":"57","author":"Wang","year":"2016","journal-title":"Leuk Lymphoma."},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2018.03.005","article-title":"Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia","author":"Sedek","year":"2018","journal-title":"J Immunol Methods"},{"key":"B148","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.4049\/jimmunol.167.10.6021","article-title":"Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways","volume":"167","author":"Buggins","year":"2001","journal-title":"J Immunol."},{"key":"B149","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/bjh.12774","article-title":"Contribution of CD39 to the immunosuppressive microenvironment of acute myeloid leukaemia at diagnosis","volume":"165","author":"Dulphy","year":"2014","journal-title":"Br J Haematol."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.3389\/fimmu.2017.01918","article-title":"ATP release from chemotherapy-treated dying leukemia cells elicits an immune suppressive effect by increasing regulatory T cells and tolerogenic dendritic cells","volume":"8","author":"Lecciso","year":"2017","journal-title":"Front Immunol."},{"key":"B151","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s13045-019-0728-3","article-title":"Downregulation of CD73 associates with T cell exhaustion in AML patients","volume":"12","author":"Kong","year":"2019","journal-title":"J Hematol Oncol."},{"key":"B152","doi-asserted-by":"publisher","first-page":"eaaw4304","DOI":"10.1126\/sciadv.aaw4304","article-title":"Mutant CEBPA directly drives the expression of the targetable tumor-promoting factor CD73 in AML","volume":"5","author":"Jakobsen","year":"2019","journal-title":"Sci Adv."},{"key":"B153","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1182\/blood.V99.11.4087","article-title":"B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes","volume":"99","author":"Damle","year":"2002","journal-title":"Blood."},{"key":"B154","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1365-2141.2007.06790.x","article-title":"B-cell chronic lymphocytic leukaemia cells show specific changes in membrane protein expression during different stages of cell cycle","volume":"139","author":"Bennett","year":"2007","journal-title":"Br J Haematol."},{"key":"B155","doi-asserted-by":"publisher","first-page":"6141","DOI":"10.1182\/blood-2011-08-374728","article-title":"CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell death","volume":"118","author":"Serra","year":"2011","journal-title":"Blood."},{"key":"B156","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1080\/10428190902803677","article-title":"Enhanced formation and survival of CD4+ CD25hi Foxp3+ T-cells in chronic lymphocytic leukemia","volume":"50","author":"Jak","year":"2009","journal-title":"Leuk Lymphoma."},{"key":"B157","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1182\/bloodadvances.2016000984","article-title":"Adenosine signaling mediates hypoxic responses in the chronic lymphocytic leukemia microenvironment","volume":"1","author":"Serra","year":"2016","journal-title":"Blood Adv."},{"key":"B158","doi-asserted-by":"publisher","first-page":"113","DOI":"10.3109\/10428194.2014.907893","article-title":"Ectonucleoside triphosphate diphosphohydrolase-1 (E-NTPDase1\/CD39) as a new prognostic marker in chronic lymphocytic leukemia","volume":"56","author":"Abousamra","year":"2015","journal-title":"Leuk Lymphoma."},{"key":"B159","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1182\/blood-2004-03-1046","article-title":"Quantitative analysis of nucleoside transporter and metabolism gene expression in chronic lymphocytic leukemia (CLL): identification of fludarabine-sensitive and -insensitive populations","volume":"105","author":"Mackey","year":"2005","journal-title":"Blood."},{"key":"B160","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/onc.2016.206","article-title":"Extracellular purines, purinergic receptors and tumor growth","volume":"36","author":"Di Virgilio","year":"2017","journal-title":"Oncogene."},{"key":"B161","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1002\/ijc.32144","article-title":"Tumor CD73\/A2aR adenosine immunosuppressive axis and tumor-infiltrating lymphocytes in diffuse large B-cell lymphoma: correlations with clinicopathological characteristics and clinical outcome","volume":"145","author":"Wang","year":"2019","journal-title":"Int J Cancer."},{"key":"B162","doi-asserted-by":"publisher","first-page":"6157","DOI":"10.4049\/jimmunol.0900475","article-title":"Human follicular lymphoma CD39+-infiltrating T cells contribute to adenosine-mediated T cell hyporesponsiveness","volume":"183","author":"Hilchey","year":"2009","journal-title":"J Immunol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1182\/blood-2017-10-764373","article-title":"Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions","volume":"131","author":"Puente","year":"2018","journal-title":"Blood."},{"key":"B164","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/164_2017_12","article-title":"Mechanisms of resistance to targeted therapies in chronic lymphocytic leukemia","volume":"249","author":"Arruga","year":"2018","journal-title":"Handb Exp Pharmacol."},{"key":"B165","doi-asserted-by":"publisher","first-page":"2906","DOI":"10.1016\/j.febslet.2012.07.016","article-title":"Regulation of CLL survival by hypoxia-inducible factor and its target genes","volume":"586","author":"Shachar","year":"2012","journal-title":"FEBS Lett."},{"key":"B166","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1172\/JCI0215337","article-title":"Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia","volume":"110","author":"Synnestvedt","year":"2002","journal-title":"J Clin Invest."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.3389\/fimmu.2017.01887","article-title":"Accomplices of the hypoxic tumor microenvironment compromising antitumor immunity: adenosine, lactate, acidosis, vascular endothelial growth factor, potassium ions, and phosphatidylserine","volume":"8","author":"Vaupel","year":"2017","journal-title":"Front Immunol."},{"key":"B168","doi-asserted-by":"publisher","first-page":"897","DOI":"10.4049\/jimmunol.1701414","article-title":"The hypoxia-adenosine link during intestinal inflammation","volume":"200","author":"Bowser","year":"2018","journal-title":"J Immunol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J Clin Invest."},{"key":"B170","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/leu.2015.187","article-title":"Metabolic plasticity in CLL: adaptation to the hypoxic niche","volume":"30","author":"Koczula","year":"2016","journal-title":"Leukemia."},{"key":"B171","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/leu.2012.165","article-title":"Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function","volume":"27","author":"DiLillo","year":"2013","journal-title":"Leukemia."},{"key":"B172","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.2147\/OTT.S49480","article-title":"Potential role of daratumumab in the treatment of multiple myeloma","volume":"7","author":"Khagi","year":"2014","journal-title":"Onco Targets Ther."},{"key":"B173","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/intimm\/dxy040","article-title":"Anti-leukemic effects of all-trans retinoic acid in combination with Daratumumab in acute myeloid leukemia","volume":"30","author":"Buteyn","year":"2018","journal-title":"Int Immunol."},{"key":"B174","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1182\/blood-2017-06-740944","article-title":"CD38 antibodies in multiple myeloma: back to the future","volume":"131","author":"van de Donk","year":"2018","journal-title":"Blood."},{"key":"B175","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/bjh.15121","article-title":"Current use of monoclonal antibodies in the treatment of multiple myeloma","volume":"181","author":"Varga","year":"2018","journal-title":"Br J Haematol."},{"key":"B176","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.4049\/jimmunol.1003032","article-title":"Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors","volume":"186","author":"de Weers","year":"2011","journal-title":"J Immunol."},{"key":"B177","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1080\/19420862.2015.1007813","article-title":"Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma","volume":"7","author":"Overdijk","year":"2015","journal-title":"MAbs."},{"key":"B178","doi-asserted-by":"publisher","first-page":"807","DOI":"10.4049\/jimmunol.1501351","article-title":"The therapeutic CD38 monoclonal antibody daratumumab induces programmed cell death via fcgamma receptor-mediated cross-linking","volume":"197","author":"Overdijk","year":"2016","journal-title":"J Immunol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1158\/1078-0432.CCR-18-1597","article-title":"The mechanism of action of the anti-CD38 monoclonal antibody isatuximab in multiple myelmoa","volume":"25","author":"Moreno","year":"2019","journal-title":"Clin Cancer Res."},{"key":"B180","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.3389\/fimmu.2018.02134","article-title":"CD38 antibodies in multiple myeloma: mechanisms of action and modes of resistance","volume":"9","author":"van de Don","year":"2018","journal-title":"Front Immunol."},{"key":"B181","doi-asserted-by":"publisher","first-page":"3939","DOI":"10.1016\/j.bmcl.2011.05.022","article-title":"Flavonoids as inhibitors of human CD38","volume":"21","author":"Kellenberger","year":"2011","journal-title":"Bioorg Med Chem Lett."},{"key":"B182","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.3389\/fimmu.2017.01936","article-title":"Monoclonal antibody therapies for hematological malignancies: not just lineage-specific targets","volume":"8","author":"Cuesta-Mateos","year":"2017","journal-title":"Front Immunol."},{"key":"B183","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1126\/science.1208347","article-title":"Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice","volume":"334","author":"Michaud","year":"2011","journal-title":"Science."},{"key":"B184","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1053\/j.gastro.2010.05.007","article-title":"CD39\/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice","volume":"139","author":"Sun","year":"2010","journal-title":"Gastroenterology."},{"key":"B185","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1038\/onc.2012.269","article-title":"ENTPD1\/CD39 is a promising therapeutic target in oncology","volume":"32","author":"Bastid","year":"2013","journal-title":"Oncogene."},{"key":"B186","first-page":"129","article-title":"Anti-CD39 and anti-CD73 antibodies A1 and 7G2 improve targeted therapy in ovarian cancer by blocking adenosine-dependent immune evasion","volume":"6","author":"Hausler","year":"2014","journal-title":"Am J Transl Res."},{"key":"B187","first-page":"1181","article-title":"CD39 is a promising therapeutic antibody target for the treatment of soft tissue sarcoma","volume":"7","author":"Hayes","year":"2015","journal-title":"Am J Transl Res."},{"key":"B188","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1073\/pnas.0908801107","article-title":"Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis","volume":"107","author":"Stagg","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B189","doi-asserted-by":"publisher","first-page":"e1208875","DOI":"10.1080\/2162402X.2016.1208875","article-title":"Targeting CD73 in the tumor microenvironment with MEDI9447","volume":"5","author":"Hay","year":"2016","journal-title":"Oncoimmunology."},{"key":"B190","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1158\/0008-5472.CAN-09-3109","article-title":"CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression","volume":"70","author":"Jin","year":"2010","journal-title":"Cancer Res."},{"key":"B191","doi-asserted-by":"publisher","first-page":"6248","DOI":"10.1021\/acs.jmedchem.5b00802","article-title":"\u03b1,\u03b2-methylene-ADP (AOPCP) derivatives and analogues: development of potent and selective ecto-5'-nucleotidase (CD73) inhibitors","volume":"58","author":"Bhattarai","year":"2015","journal-title":"J Med Chem."},{"key":"B192","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fphar.2018.00266","article-title":"Nanobody-based biologics for modulating purinergic signaling in inflammation and immunity","volume":"9","author":"Menzel","year":"2018","journal-title":"Front Pharmacol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s00262-011-1155-7","article-title":"Enhancement of tumor immunotherapy by deletion of the A2A adenosine receptor","volume":"61","author":"Waickman","year":"2012","journal-title":"Cancer Immunol Immunother."},{"key":"B194","doi-asserted-by":"publisher","first-page":"14711","DOI":"10.1073\/pnas.1308209110","article-title":"Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors","volume":"110","author":"Beavis","year":"2013","journal-title":"Proc Natl Acad Sci USA."},{"key":"B195","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1158\/2326-6066.CIR-14-0211","article-title":"Adenosine receptor 2A blockade increases the efficacy of anti-PD-1 through enhanced antitumor T-cell responses","volume":"3","author":"Beavis","year":"2015","journal-title":"Cancer Immunol Res."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02301\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T08:43:29Z","timestamp":1695285809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2019.02301\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,4]]},"references-count":195,"alternative-id":["10.3389\/fimmu.2019.02301"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2019.02301","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,4]]},"article-number":"2301"}}